Report / Trial registry metadata
Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
A registered study record. Recorded registry status: RECRUITING. A registry entry is not a treatment recommendation or proof that a study succeeded.
Limits
No clinical review has been performed. This record is not a treatment recommendation, eligibility confirmation or current availability guarantee.
- Kind
- Trial registry metadata
- Status
- RECRUITING